Bio Preventive Medicine (BPM) is a leading company in renal biomarker area. As an innovative and clinical staged biotech company, BPM has focus on translating validated and IP-protected biomarkers into diagnostic solutions for unmet clinical needs, especially among the fields of diseases early detection and prevention in diabetes related complications, such as CKD and CVD, kidney injury, and oncology (upper GI cancer).
To advance precision medicine and reduce healthcare burden globally in chronic diseases and oncology, BPM develops clinically proven biomarkers and high value-added diagnostic products, that enable unprecedented efficiencies in the development of therapies. BPM constantly contribute its expertise and is seeking to partner and collaborate with leading industry organizations.
For more information, please visit: https://www.bpmbiotech.com/